Back to Research Home
RVTYRevvity Inc.
Health Care · Health Care Equipment · Large
$158.77+0.90%
As of 23 Oct 2026Mkt cap $14.6B
Stage 13
AVOID
Fundamentals
31.8/75
Technical
5.5/15
Independent
37.3/90
GCAE viewFundamental /75 is below the Stage 13 acceptable-business floor
Price
- 1M
- +5.4%
- 3M
- +46.9%
- 6M
- +83.0%
- 1Y
- +65.9%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 75.6xHist median 47.2x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 33.2x
- FCF yield
- 3.0%
Quality
- ROIC
- 3.4%
- Operating margin
- 12.5%
- FCF margin
- 17.8%
- Current ratio
- 1.7x
Growth
- Revenue growth
- +3.7%Latest FY YoY
- Revenue CAGR
- −7.1%
- EPS CAGR
- −28.9%
- FCF CAGR
- −21.3%
Capital
- Share-count trend
- −3.3%3Y annualised
- Net debt
- $1.7B3.0x OCF
Annual trend
- CAGR 2021–2025
- −7.1%
- Latest · 2025
- $3B
- YoY
- +3.7%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- FUNDAMENTAL DECELERATION
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
Fundamental /75 is below the Stage 13 acceptable-business floor
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-11-03
More details & evidence
Production decision
- Stage 13
- AVOID
- Technical state
- extended
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded